Drug Recalls

Here you'll find every drug recall the FDA has issued, including prescription medications, over-the-counter drugs, compounded pharmacy products, and dietary supplements. We've been tracking these since 2006 and our database updates several times a day so you're always looking at current information.

Drugs get recalled for a number of reasons: contamination during manufacturing, incorrect potency or dosage, failed quality testing (like dissolution or stability tests), sterility problems in injectable products, or labeling and packaging errors that could cause someone to take the wrong dose. If you find a product on this list that you use, please follow the instructions provided by the FDA to take the necessary precautions.

17,529 total recalls
2 this month

Showing 1201–1220 of 17,529 recalls

May 14, 2024· Imprimis NJOF, LLC

Recalled Item: Moxifloxacin 0.8 mg/0.8 mL Preservative-Free 0.8mL Single-Use vials for...

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
May 14, 2024· Imprimis NJOF, LLC

Recalled Item: Epinephrine-Lidocaine HCl 0.25 mg/mL and 7.5 mg/mL Preservative-Free 1mL...

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
May 14, 2024· Imprimis NJOF, LLC

Recalled Item: Dexamethasone-Moxifloxacin (1 mg/mL and 5mg/mL) Preservative-Free

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
May 14, 2024· Imprimis NJOF, LLC

Recalled Item: Epinephrine-Lidocaine HCl 0.25 mg/mL and 7.5 mg/mL Preservative-Free 1mL...

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
May 14, 2024· American Regent, Inc.

Recalled Item: niCARdipine Hydrochloride Injection

The Issue: Sterility Concerns

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
May 13, 2024· Golden State Medical Supply Inc.

Recalled Item: Duloxetine Delayed-Release Capsules

The Issue: CGMP Deviations: Presence of Nitrosamine Drug Substance Related

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
May 13, 2024· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Rizatriptan Benzoate Orally Disintegrating Tablets

The Issue: CGMP Deviations: N-Nitroso Desmethyl Rizatriptan Impurity results that

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
May 13, 2024· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Rizatriptan Benzoate Orally Disintegrating Tablets

The Issue: CGMP Deviations: N-Nitroso Desmethyl Rizatriptan Impurity results that

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
May 13, 2024· American Regent, Inc.

Recalled Item: Vasopressin Injection

The Issue: Subpotent product in addition to having out-of-specification results

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
May 10, 2024· Bryant Ranch Prepack, Inc.

Recalled Item: Cephalexin for Oral Suspension

The Issue: Labeling: Not Elsewhere Classified: Back Label states 'Each

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
May 10, 2024· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Rizatriptan Benzoate Tablets USP

The Issue: CGMP Deviations: N-Nitroso Desmethyl Rizatriptan Impurity results that

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
May 10, 2024· Bryant Ranch Prepack, Inc.

Recalled Item: Cephalexin for Oral Suspension

The Issue: Labeling: Not Elsewhere Classified: Front label states 100

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
May 10, 2024· Bryant Ranch Prepack, Inc.

Recalled Item: Cephalexin for Oral Suspension

The Issue: Labeling: Not Elsewhere Classified: Back label states Each

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
May 10, 2024· Bryant Ranch Prepack, Inc.

Recalled Item: Cephalexin for Oral Suspension

The Issue: Labeling: Not Elsewhere Classified: Back Label states Each

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
May 10, 2024· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Rizatriptan Benzoate Tablets USP

The Issue: CGMP Deviations: N-Nitroso Desmethyl Rizatriptan Impurity results that

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
May 10, 2024· Bryant Ranch Prepack, Inc.

Recalled Item: Cephalexin for Oral Suspension

The Issue: Labeling: Not Elsewhere Classified: Back Label states 'Each

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
May 10, 2024· Preferred Pharmaceuticals, Inc.

Recalled Item: Duloxetine Delayed-Release Cap USP 30mg

The Issue: CGMP Deviations: Presence of N-nitroso-duloxetine impurity above FDA

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
May 8, 2024· Lupin Pharmaceuticals Inc.

Recalled Item: Cefdinir for Oral Suspension USP

The Issue: Defective container: lack of seal integrity

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardTerminated
Refund
May 7, 2024· PACIRA PHARMACEUTICALS INC

Recalled Item: Drug Vial Label: Zilretta¿ (triamcinolone acetonide extended-release...

The Issue: Failed Stability Specifications - at 12 months 2-8

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
May 7, 2024· MACLEODS PHARMA USA, INC

Recalled Item: Losartan Potassium and Hydrochlorothiazide Tablets

The Issue: Presence of foreign substance: plastic-like substance

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund